Cardinal Health (NYSE:CAH) Hits New 52-Week High – What’s Next?

Shares of Cardinal Health, Inc. (NYSE:CAH) hit a new 52-week high on Monday . The stock traded as high as $212.06 and last traded at $211.5210, with a volume of 348257 shares. The stock had previously closed at $209.48.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. UBS Group lifted their price target on shares of Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a research report on Friday, October 31st. Argus raised their price objective on shares of Cardinal Health from $189.00 to $211.00 and gave the stock a “buy” rating in a report on Tuesday, November 4th. Leerink Partners lifted their price target on Cardinal Health from $211.00 to $230.00 and gave the stock an “outperform” rating in a research note on Monday, November 17th. Robert W. Baird set a $232.00 target price on shares of Cardinal Health in a report on Friday, October 31st. Finally, TD Cowen upped their target price on Cardinal Health from $183.00 to $225.00 and gave the company a “buy” rating in a report on Monday, November 3rd. Twelve analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $206.57.

Cardinal Health Stock Performance

The stock has a 50 day moving average price of $171.23 and a 200 day moving average price of $161.23. The company has a market cap of $50.21 billion, a P/E ratio of 32.76, a P/E/G ratio of 1.39 and a beta of 0.72.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The company had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. Cardinal Health’s revenue was up 22.4% on a year-over-year basis. During the same period in the prior year, the company earned $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, equities research analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be issued a $0.5107 dividend. The ex-dividend date is Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio is currently 30.77%.

Institutional Trading of Cardinal Health

Hedge funds and other institutional investors have recently modified their holdings of the company. Counterpoint Mutual Funds LLC acquired a new stake in Cardinal Health during the second quarter valued at approximately $1,911,000. Atlantic Union Bankshares Corp bought a new position in shares of Cardinal Health in the 2nd quarter valued at about $79,000. KLP Kapitalforvaltning AS lifted its holdings in Cardinal Health by 4.0% in the second quarter. KLP Kapitalforvaltning AS now owns 114,198 shares of the company’s stock valued at $19,185,000 after buying an additional 4,400 shares during the period. Czech National Bank increased its holdings in Cardinal Health by 5.1% in the second quarter. Czech National Bank now owns 58,341 shares of the company’s stock valued at $9,801,000 after purchasing an additional 2,857 shares during the last quarter. Finally, Acadian Asset Management LLC lifted its stake in Cardinal Health by 92.5% in the second quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company’s stock valued at $282,063,000 after buying an additional 807,063 shares during the period. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.